IBALX
Price
$37.09
Change
+$0.11 (+0.30%)
Updated
Oct 17 closing price
Net Assets
1.5B
RLBEX
Price
$38.94
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.37B
Interact to see
Advertisement

IBALX vs RLBEX

Header iconIBALX vs RLBEX Comparison
Open Charts IBALX vs RLBEXBanner chart's image
Transamerica Multi-Managed Balanced A
Price$37.09
Change+$0.11 (+0.30%)
VolumeN/A
Net Assets1.5B
American Funds American Balanced R4
Price$38.94
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.37B
IBALX vs RLBEX Comparison Chart in %
View a ticker or compare two or three
VS
IBALX vs. RLBEX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IBALX is a Buy and RLBEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBEX has more cash in the bank: 265B vs. IBALX (1.5B). RLBEX pays higher dividends than IBALX: RLBEX (1.74) vs IBALX (1.39). IBALX was incepted earlier than RLBEX: IBALX (31 years) vs RLBEX (23 years). IBALX (0.97) is less costly to investors than RLBEX (0.59). RLBEX is a more actively managed with annual turnover of: 44.00 vs. IBALX (41.00). RLBEX has a lower initial minimum investment than IBALX: RLBEX (250) vs IBALX (1000). RLBEX annual gain was more profitable for investors over the last year : 8.70 vs. IBALX (3.57). RLBEX return over 5 years is better than : 42.04 vs. IBALX (23.88).
IBALXRLBEXIBALX / RLBEX
Total Expense Ratio0.970.59164%
Annual Report Gross Expense Ratio0.970.59164%
Fund Existence31 years23 years-
Gain YTD10.79014.63174%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.5B265B1%
Annual Yield % from dividends1.391.7480%
Returns for 1 year3.578.7041%
Returns for 3 years38.8550.5277%
Returns for 5 years23.8842.0457%
Returns for 10 years61.8177.6980%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ELAN21.420.90
+4.39%
Elanco Animal Health
UK1.040.01
+0.97%
Ucommune International Ltd
XBIT2.49N/A
N/A
XBiotech
WLYB36.95-0.41
-1.10%
John Wiley & Sons
JBIO9.37-0.41
-4.24%
Jade Biosciences Inc